EXAS - Clinical Trial Results for ColoRectal Cancer Screen 10/29/10

ALRT - FDA 510(k) Filing for Health-e-Connect (HeC) System — Health Care for Diabetes Patients.  ESTIMATED Date of 3/31/11

HOLX - FDA Advisory Panel for breast cancer screening / diagnosis on 9/24/10

AZN - FDA PDUFA for Brilinta 9/16/10

MKGAY - FDA Priority Review for Cladribine Tablets 12/8/10

3 Responses to “FDA Calendar Updates 7/30/10”

  1. Michael Maurice says:

    For ALRT is that 2011?

  2. veronica says:

    Is that a bad thing for alexa(alxa) the bio dilution? Im new to stocks and am trying to learn . I would like to purchase some alxa shares. This site has been a tremendous help.

Leave a Reply